Kathryn M. Connor, MD, MHS | Psychiatrist.com

Original Research

Placebo-Controlled Trial of Risperidone Augmentation for Selective Serotonin Reuptake Inhibitor-Resistant Civilian Posttraumatic Stress Disorder

March 18, 2008

Kathleen T. Brady, Barbara O. Rothbaum, Kathryn M. Connor, et al

Original Research

Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy

March 14, 2008

Kathryn M. Connor, Jonathan R. T. Davidson, Murray B. Stein, et al

Article

Assessment of Resilience in the Aftermath of Trauma

February 15, 2006

Kathryn M. Connor

Article

Practical Assessment and Evaluation of Mental Health Problems Following a Mass Disaster

February 15, 2006

Kathryn M. Connor, Jonathan R. T. Davidson, Edna B. Foa

Original Research

Botulinum Toxin Treatment of Social Anxiety Disorder With Hyperhidrosis: A Placebo-Controlled Double-Blind Trial.

January 16, 2006

Kathryn M. Connor, Jonathan R. T. Davidson, Jonathan L. Cook

Original Research

The Use of Aripiprazole in Obsessive-Compulsive Disorder: Preliminary Observations in 8 Patients

January 15, 2005

Kathryn M. Connor, Victoria M. Payne, Kishore M. Gadde, et al

Article

Effective Recognition and Treatment of Generalized Anxiety Disorder in Primary Care

April 1, 2004

Larry Culpepper, Kathryn M. Connor

Article

Management of Posttraumatic Stress Disorder: Diagnostic and Therapeutic Issues

June 1, 1999

Kathryn M. Connor, Jonathan R. T. Davidson

Article

Bupropion Sustained Release: A Therapeutic Overview

April 1, 1998

Kathryn M. Connor, Jonathan R. T. Davidson